Heron Therapeutics (HRTX) EBIT Growth (1y) (2011 - 2026)
Heron Therapeutics (HRTX) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
100.00% |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
12.69% |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
75.16% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-347.04% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
1.27% |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
-230.00% |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
80.62% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Heron Therapeutics |
76.81 Mn |
46.84 Mn |
24.07 Mn |
-251.08% |
| Date | Value |
|---|
| Mar 31, 2026 |
-251.08% |
| Dec 31, 2025 |
-99.09% |
| Sep 30, 2025 |
8.19% |
| Jun 30, 2025 |
74.60% |
| Mar 31, 2025 |
165.74% |
| Dec 31, 2024 |
140.83% |
| Sep 30, 2024 |
82.12% |
| Jun 30, 2024 |
84.80% |
| Mar 31, 2024 |
85.49% |
| Dec 31, 2023 |
49.79% |
| Sep 30, 2023 |
40.48% |
| Jun 30, 2023 |
14.33% |
| Mar 31, 2023 |
47.45% |
| Dec 31, 2022 |
61.98% |
| Sep 30, 2022 |
19.00% |
| Jun 30, 2022 |
18.14% |
| Mar 31, 2022 |
-20.74% |
| Dec 31, 2021 |
12.66% |
| Sep 30, 2021 |
11.43% |
| Jun 30, 2021 |
-8.47% |
